SCHEMBL30641024

SCHEMBL30641024

CN(C)c1ccc(-c2ccn3c(=O)n(CC(CN)=C(F)F)nc3c2)cn1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GRM2 Q14416 1/20 0.36
▸ GPR139 Q6DWJ6 11/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.34
▸ PSD A5PKW4 1/20 0.33
▸ MAP3K11 Q16584 1/20 0.32
▸ PIK3CD O00329 1/20 0.31
▸ PIK3CA P42336 1/20 0.31
▸ PIK3CB P42338 1/20 0.31
▸ PI4KA P42356 1/20 0.31
▸ PIK3CG P48736 1/20 0.31
▸ PI4KB Q9UBF8 1/20 0.31
▸ TDO2 P48775 1/20 0.31
▸ ICMT O60725 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22092135 1.00 GRM2 (0.36) GRM2GPR139NPC1POLBGAA
Trifluoroacetic Acid SCHEMBL22092166 0.94 GPR139 (0.34) GRM2GPR139NPC1POLBGAA
SCHEMBL22098839 0.86 NPC1 (0.35) GRM2GPR139NPC1POLBGAA
Hydrochloric Acid SCHEMBL22206329 0.85 NPC1 (0.34) GRM2GPR139NPC1POLBGAA
SCHEMBL30641014 0.84 GPR139 (0.37) GPR139PIK3CA
SCHEMBL22092076 0.84 GPR139 (0.37) GPR139PIK3CA
SCHEMBL22098775 0.83 MCHR1 (0.37) GPR139PIK3CDPIK3CAPIK3CBPI4KA
Trifluoroacetic Acid SCHEMBL22092139 0.80 MCHR1 (0.35) GPR139PIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL22098776 0.79 FLT3 (0.41) GPR139PIK3CGTDO2
SCHEMBL22092061 0.78 PRMT5 (0.39) GPR139PIK3CDPIK3CAPIK3CBPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820769-B2 Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same YUHAN CORPORATION (KR) 2023-11-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11820769-B2 Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same VAPB, HDLBP, VAPA GRM2 4441/4885GPR139 4033/4885NPC1 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback